Navigation Links
PCAS : Tighter Links Between PCAS and Proteus
Date:10/22/2007

LONGJUMEAU, France, October 22 /PRNewswire-FirstCall/ -- Proteus today announced the completion of a share capital increase reserved for Proteus' industrial partner PCAS. PCAS' stake in Proteus now represents 32% of the issued share capital vs 6% before the increase. Proceeds of this private placement are to be used to accelerate the growth of PROTEUS' PSI and PCAS BIOSOLUTION businesses.

PROTEUS (http://www.proteus.fr) is a biotech company discovering, optimizing, developing and producing new proteins and biotechnological processes for pharmaceuticals, cosmetics, fine chemicals, environmental and other industrial applications. PROTEUS' business is backed by a unique set of technologies, know how and intellectual property portfolio including exclusive resources in natural microbial biodiversity and proprietary technologies for screening, engineering and producing proteins.

PROTEUS offers a range of exclusive solutions for protein manufacturing and engineering through a dedicated business unit "PSI" (Proteus Services for Industry) and through exclusive industrial partnerships. The new proteins and process developed by PROTEUS reinforce the competitive edge and intellectual property position of its clients.

PCAS and PROTEUS already entered into close partnership by forming PCAS BIOSOLUTION, a 50/50 joint venture. The mission of PCAS BIOSOLUTION (http://www.pcas-bio.com) is to design, develop and industrialize new manufacturing routes to produce pharmaceutical intermediates and actives compounds ("API"). The new routes combines chemical processes developed by PCAS and enzymatic catalytic processes ("biocatalysis") developed by PROTEUS.

PCAS thus reinforces its position in "green chemistry", providing its clients with all the benefits of integrating chemistry and biotechnology. The new chemo-biocatalytic processes developed at PCAS BIOSOLUTION enable to access to complex pharmaceutical intermediates while reducing the number of steps of the manufacturing process, lowering the production costs and reducing the amount of waste. With PCAS BIOSOLUTION, PROTEUS improves and widens its offering to the life science industry by providing industrial manufacturing services backed by the expertise and industrial capabilities of PCAS, a leading European player in the field.

PCAS (http://www.pcas.fr) is a group listed on the Eurolist compartment C (ISIN FR0000053514), specialized in fine and specialty chemicals. It develops and manufactures high added-value molecules or molecules of a strong technological content for the pharmaceutical, perfume, cosmetic and industrial sectors.

Contact :

Gérard Guillamot,

+33(0)1-69-79-60-08

http://www.pcas.fr


'/>"/>
SOURCE PCAS
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Investor links East Coast funds to Midwest tech
2. UW links with Israeli school to locate genes
3. New Dane County airport links to Atlanta announced
4. Big collaboration links learners to science on a tiny scale
5. ARI Links e-Catalog Deal with Outdoor Power Equipment Manufacturer
6. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
7. Quantitative Measurement of Cell Proliferation Using the BrdU ELISA: A Comparison Between Colorimetric and Chemiluminescent Detection
8. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
9. Comparison of Performance between the AlphaQuest - HTS and the Fusion α Multilabel Reader for Detection of cAMP
10. Single gene controls key difference between maize and its wild ancestor
11. Line between big pharma, big biotech continues to blur
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
Breaking Biology Technology:
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 /PRNewswire/ ... product subsidiary of Infosys (NYSE: INFY ), and ... global partnership that will provide end customers with ... banking and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... area for financial services, but it also plays a fundamental ...
Breaking Biology News(10 mins):